LOS ANGELES, CA--(Marketwire - August 12, 2008) - Clearant, Inc. (OTCBB: CLRA), owner of the Clearant Process® designed to substantially reduce all types of pathogens in biological products including HIV, today announced that preliminary revenues for the 2nd quarter ending June 30, 2008 increased 194% to $0.50 million compared to $0.17 million in the 2nd quarter 2007.
